Related Experiment Videos
[Flow cytometric DNA analysis in colorectal cancer]
Y Ando1, A Tsuchiya, K Sekikawa
1Department of Surgery II, Fukushima Medical College, Japan.
Nihon Geka Gakkai Zasshi
|September 1, 1989
Summary
Flow cytometry DNA analysis of colorectal cancer reveals aneuploid tumors correlate with significantly worse patient survival, independent of pathological stage. This DNA content is a crucial prognostic factor.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Context:
- Colorectal carcinoma presents a significant global health challenge.
- Accurate prognostic markers are crucial for effective patient management.
- Flow cytometric DNA analysis offers a method to assess cellular DNA content.
Purpose:
- To investigate the utility of flow cytometric DNA analysis in paraffin-embedded colorectal cancer tissues.
- To determine if nuclear DNA content (ploidy) correlates with patient survival and clinicopathological factors.
- To establish DNA content as a potential prognostic indicator for colorectal cancer.
Summary:
- Nuclear DNA content was measured in 144 primary colorectal cancer patients using flow cytometry on deparaffinized tumor specimens.
- Forty-four percent of tumors were diploid, and 56% were aneuploid.
- Aneuploid tumors showed significantly worse survival rates compared to diploid tumors (p < 0.001), irrespective of pathological stage or nodal status.
Impact:
- Findings suggest that nuclear DNA content is an independent prognostic factor for colorectal cancer.
- This analysis can aid in stratifying patients and predicting outcomes.
- The study validates the use of paraffin-embedded tissues for reliable DNA content assessment.